147 related articles for article (PubMed ID: 11260250)
21. Mastocytosis associated with severe wasp sting anaphylaxis detected by elevated serum mast cell tryptase levels.
Biedermann T; Ruëff F; Sander CA; Przybilla B
Br J Dermatol; 1999 Dec; 141(6):1110-2. PubMed ID: 10606862
[TBL] [Abstract][Full Text] [Related]
22. Assessment of in vivo mast cell reactivity in patients with systemic mastocytosis.
Gülen T; Möller Westerberg C; Lyberg K; Ekoff M; Kolmert J; Bood J; Öhd J; James A; Dahlén SE; Nilsson G; Dahlén B
Clin Exp Allergy; 2017 Jul; 47(7):909-917. PubMed ID: 28258965
[TBL] [Abstract][Full Text] [Related]
23. Response to cyclosporin and low-dose methylprednisolone in aggressive systemic mastocytosis.
Kurosawa M; Amano H; Kanbe N; Igarashi Y; Nagata H; Yamashita T; Kurimoto F; Miyachi Y
J Allergy Clin Immunol; 1999 May; 103(5 Pt 2):S412-20. PubMed ID: 10329843
[TBL] [Abstract][Full Text] [Related]
24. Increased Excretion of Mast Cell Mediator Metabolites During Mast Cell Activation Syndrome.
Butterfield JH
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2542-2546. PubMed ID: 36863614
[TBL] [Abstract][Full Text] [Related]
25. Induction of tryptase and histamine release from human colon mast cells by IgE dependent or independent mechanisms.
He SH; Xie H; He YS
World J Gastroenterol; 2004 Feb; 10(3):319-22. PubMed ID: 14760749
[TBL] [Abstract][Full Text] [Related]
26. Higher mast cell load decreases the risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis.
van Anrooij B; van der Veer E; de Monchy JG; van der Heide S; Kluin-Nelemans JC; van Voorst Vader PC; van Doormaal JJ; Oude Elberink JN
J Allergy Clin Immunol; 2013 Jul; 132(1):125-30. PubMed ID: 23498593
[TBL] [Abstract][Full Text] [Related]
27. The release of histamine is associated with the inactivation of mast cell chymase during immediate allergic wheal reaction in the skin.
Saarinen JV; Harvima RJ; Naukkarinen A; Horsmanheimo M; Harvima IT
Clin Exp Allergy; 2001 Apr; 31(4):593-601. PubMed ID: 11359428
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous and systemic mastocytosis in adults. A clinical, histopathological and immunological evaluation in relation to histamine metabolism.
Olafsson JH
Acta Derm Venereol Suppl (Stockh); 1985; 115():1-43. PubMed ID: 3901645
[TBL] [Abstract][Full Text] [Related]
29. Mast cells in cutaneous mastocytosis: accumulation of the MCTC type.
Irani AA; Garriga MM; Metcalfe DD; Schwartz LB
Clin Exp Allergy; 1990 Jan; 20(1):53-8. PubMed ID: 2310982
[TBL] [Abstract][Full Text] [Related]
30. Thymic stromal lymphopoietin (TSLP) is a substrate for tryptase in patients with mastocytosis.
Marcella S; Petraroli A; Canè L; Ferrara AL; Poto R; Parente R; Palestra F; Cristinziano L; Modestino L; Galdiero MR; Monti M; Marone G; Triggiani M; Varricchi G; Loffredo S
Eur J Intern Med; 2023 Nov; 117():111-118. PubMed ID: 37500310
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells.
Veien M; Szlam F; Holden JT; Yamaguchi K; Denson DD; Levy JH
Anesthesiology; 2000 Apr; 92(4):1074-81. PubMed ID: 10754628
[TBL] [Abstract][Full Text] [Related]
32. Different patterns of mast cell activation by muscle relaxants in human skin.
Koppert W; Blunk JA; Petersen LJ; Skov P; Rentsch K; Schmelz M
Anesthesiology; 2001 Sep; 95(3):659-67. PubMed ID: 11575539
[TBL] [Abstract][Full Text] [Related]
33. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
Butterfield JH; Weiler CR
Int Arch Allergy Immunol; 2008; 147(4):338-43. PubMed ID: 18622141
[TBL] [Abstract][Full Text] [Related]
34. Neuropeptide blood levels correlate with mast cell load in patients with mastocytosis.
Maintz L; Wardelmann E; Walgenbach K; Fimmers R; Bieber T; Raap U; Novak N
Allergy; 2011 Jul; 66(7):862-9. PubMed ID: 21284654
[TBL] [Abstract][Full Text] [Related]
35. Comparison of serum tryptase and urine N-methylhistamine in patients with suspected mastocytosis.
van Toorenenbergen AW; Oranje AP
Clin Chim Acta; 2005 Sep; 359(1-2):72-7. PubMed ID: 15913591
[TBL] [Abstract][Full Text] [Related]
36. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization.
Patella V; Marinò I; Lampärter B; Arbustini E; Adt M; Marone G
J Immunol; 1995 Mar; 154(6):2855-65. PubMed ID: 7533185
[TBL] [Abstract][Full Text] [Related]
37. Inhibitors of tryptase as mast cell-stabilizing agents in the human airways: effects of tryptase and other agonists of proteinase-activated receptor 2 on histamine release.
He S; Aslam A; Gaça MD; He Y; Buckley MG; Hollenberg MD; Walls AF
J Pharmacol Exp Ther; 2004 Apr; 309(1):119-26. PubMed ID: 14722328
[TBL] [Abstract][Full Text] [Related]
38. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
39. The spectrum of mastocytosis.
Tharp MD
Am J Med Sci; 1985 Mar; 289(3):119-32. PubMed ID: 2579553
[TBL] [Abstract][Full Text] [Related]
40. [Effect of tryptase inhibitors on histamine release from human colon mast cells].
Xie H; He SH; Cheng MH; Fu YL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):678-81. PubMed ID: 15555433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
